- Home
- WMK vs ARWR Comparison
WMK vs ARWR Comparison
Compare WMK & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- ARWR
- Stock Information
- Founded
- WMK 1912
- ARWR 2003
- Country
- WMK United States
- ARWR United States
- Employees
- WMK N/A
- ARWR N/A
- Industry
- WMK Food Chains
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- WMK Consumer Staples
- ARWR Health Care
- Exchange
- WMK Nasdaq
- ARWR Nasdaq
- Market Cap
- WMK 2.2B
- ARWR 1.8B
- IPO Year
- WMK N/A
- ARWR 1993
- Fundamental
- Price
- WMK $80.68
- ARWR $13.03
- Analyst Decision
- WMK
- ARWR Buy
- Analyst Count
- WMK 0
- ARWR 11
- Target Price
- WMK N/A
- ARWR $41.44
- AVG Volume (30 Days)
- WMK 135.8K
- ARWR 1.6M
- Earning Date
- WMK 05-07-2025
- ARWR 05-12-2025
- Dividend Yield
- WMK 1.72%
- ARWR N/A
- EPS Growth
- WMK 6.00
- ARWR N/A
- EPS
- WMK 3.99
- ARWR N/A
- Revenue
- WMK $4,810,301,000.00
- ARWR $2,500,000.00
- Revenue This Year
- WMK N/A
- ARWR $4,380.43
- Revenue Next Year
- WMK N/A
- ARWR $64.24
- P/E Ratio
- WMK $20.26
- ARWR N/A
- Revenue Growth
- WMK 1.70
- ARWR N/A
- 52 Week Low
- WMK $60.93
- ARWR $9.57
- 52 Week High
- WMK $88.60
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- WMK 44.46
- ARWR 47.38
- Support Level
- WMK $80.81
- ARWR $12.44
- Resistance Level
- WMK $90.23
- ARWR $14.97
- Average True Range (ATR)
- WMK 2.60
- ARWR 0.74
- MACD
- WMK -0.52
- ARWR 0.11
- Stochastic Oscillator
- WMK 16.10
- ARWR 37.01
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.